CONTROL BIONICS LIMITED — Regulatory Filings 2021

Feb 22, 2021

==> picture [102 x 36] intentionally omitted <==

23 February 2021

ASX ANNOUNCEMENT

Results for half year ended 31 December 2020 Webinar Details

Control Bionics Ltd (ASX:CBL) will announce its financial results for the half year ended 31 December, 2020 on Thursday, 25 February, 2021.

Control Bionics CEO, Robert Wong, will host a Zoom webinar at 11.00am AEST on 25 February for investors and analysts to discuss the results. Incoming CFO Neale Java will also be on the call.

Participants can register for the webinar via the following link: https://controlbionics.zoom.us/webinar/register/WN_in_56u1ZRo2PcJdnDeQXvQ

This announcement was authorised by the CEO, Rob Wong.

Investors

Rob Wong CEO robwong@controlbionics.com

Media

M&C Partners Melissa Hamilton Melissa.hamilton@mcpartners.com.au

For further information visit the website: https://www.controlbionics.com/

About Control Bionics:

Control Bionics is a technology company which enables a disabled person to use their own neuroelectric signals, from their brain to a muscle, to control communication and movement through smartphones, tablets, computers and robotics, even when that muscle is not fully functional. The Company’s wireless wearable device, ‘ NeuroNode ’, is a world leader in electromyography (EMG), capturing and processing those neuroelectric signals into electronic commands to do everything they would normally do with a keyboard, mouse, joystick or touchscreen. The technology also enables a person to use their eyes to replace a mouse in controlling a cursor on a screen simply by looking where they want the cursor to move; and then to select anything under the cursor, using NeuroNode; providing fast, intuitive communication and control through text, text-to-speech, emails, phone-messaging, web surfing and robotics.

Control Bionics Limited

Registered Office: Suite G.03, 171 Union Road, Surrey Hills, VIC, 3127 T: +61 3 9897 3576 W: www.controlbionics.com

ABN: 45 115 465 462